Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Larisa Kuzmina"'
Autor:
Elena Parovichnikova, Irina Lukianova, Irina Galtzeva, Anastasiya Kashlakova, Zalina Fidarova, Olga Aleshina, Larisa Kuzmina, Vera Troitskaya, Mikhail Drokov, Andrey Sokolov, Sergej Bondarenko, Olga Samoilova, Mariya Grishunina, Tatiana Konstantinova, Yuliya Sveshnikova, Natalia Minaeva, Elena Zinina, Valerij Lapin, Kamil Kaplanov, Sergej Gritsaev, Elena Gribanova, Valentina Dvirnyk, Tatiana Obukhova, Andrej Sudarikov, Yuliya Chabaeva
Publikováno v:
HemaSphere, Vol 7, p e64022c0 (2023)
Externí odkaz:
https://doaj.org/article/7e45f48855404875a3a21cb787da5609
Autor:
Anna Dmitrova, Mikhail Drokov, Tatiana Tupoleva, Dmitriy Tikhomirov, Grigoriy Efimov, Apollinariya Bogolyubova, Alexandra Maleeva, Murad Vagida, Zalina Fidarova, Evgeniy Zvonkov, Larisa Kuzmina, Elena Parovichnikova
Publikováno v:
HemaSphere, Vol 7, p e2682889 (2023)
Externí odkaz:
https://doaj.org/article/9d0ad2caaa22439ab74402b49a7fb3c7
Autor:
Mobil Akhmedov, Galina Klyasova, Larisa Kuzmina, Anastasia Fedorova, Mikhail Drokov, Elena Parovichnikova
Publikováno v:
Leukemia & Lymphoma. :1-10
Autor:
Mikhail Drokov, Galina Yatsyk, Anna Kireeva, Olga Pirikova, Darya Dubnyak, Larisa Kuzmina, Vera Vasilyeva, Natalia Popova, Olga Starikova, Elena Parovichnikova, Valeriy Savchenko
Publikováno v:
International Journal of Hematology. 115:545-552
Acute graft-versus-host-disease (aGVHD) develops in 10-80% of allo-HSCT patients. More than half of all aGVHD cases are refractory to first-line therapy with steroids. We hypothesized that bowel wall thickness at the time of aGVHD diagnosis could be
Autor:
Mobil Akhmedov, Galina Klyasova, Larisa Kuzmina, Anastasia Fedorova, Mikhail Drokov, Elena Parovichnikova
Publikováno v:
Infection & Chemotherapy. 55
Autor:
Nataliya Petinati, Nina Drize, Natalia Sats, Natalya Risinskaya, Andrey Sudarikov, Michail Drokov, Daria Dubniak, Alina Kraizman, Maria Nareyko, Natalia Popova, Maya Firsova, Larisa Kuzmina, Elena Parovichnikova, Valeriy Savchenko
Publikováno v:
Stem Cells International, Vol 2018 (2018)
Multipotent mesenchymal stromal cells (MSCs) participate in the formation of bone marrow niches for hematopoietic stem cells. Donor MSCs can serve as a source of recovery for niches in patients with graft failure (GF) after allogeneic bone marrow (BM
Externí odkaz:
https://doaj.org/article/14342963080642c897778c2d280fd129
Publikováno v:
Expert review of anti-infective therapy.
Although colonization is an established risk factor for bloodstream infection (BSI) due to identical strain, prior infection with resistant bacteria should also be considered during the management of febrile neutropenia. This study aimed to analyze t
Autor:
Olga Dubova, Natalya Risinskaya, Anna Yushkova, Firuza Shikhveledova, Mikhail Drokov, Hunan Julhakyan, Larisa Kuzmina, Andrey Sudarikov
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S444-S445
Autor:
Mobil Akhmedov, Galina Klyasova, Larisa Kuzmina, Anastasia Fedorova, Vera Vasilyeva, Mikhail Drokov, Elena Parovichnikova
Publikováno v:
Transplant Infectious Disease. 24
With an increasing number of allogeneic hematopoietic cell transplantations (allo-HCT) bloodstream infections (BSI) are still among the most common and serious complications. This study aimed to analyze the incidence, etiology, risk factors, and outc
Autor:
Nataliya Petinati, Yulia Davydova, Ksenia Nikiforova, Alexey Bigildeev, Alexander Belyavsky, Georgiy Arapidi, Nina Drize, Larisa Kuzmina, Elena Parovichnikova, Valeriy Savchenko
Publikováno v:
Transplantation and Cellular Therapy. 29:109.e1-109.e10
Multipotent mesenchymal stromal cells (MSCs) are currently under intensive investigation for the treatment and prevention of graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT), owing to their substan